European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Evaluating drug policy: a seven-step guide to support the commissioning and managing of evaluations. Luxembourg: Publications Office of the European Union. 30 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Online policy and practice briefings: Older people with problematic opioid use. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Drug treatment expenditure: a methodological overview, EMCDDA Insights 24. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Health and social responses to drug problems: a European guide. Luxembourg: Publications Office of the European Union. 188 p.

European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA–Europol Joint Report on a new psychoactive substance: N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA). Luxembourg: Joint Reports, Publications Office of the European Union. 15 p.

European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA–Europol Joint Report on a new psychoactive substance: N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyrylfentanyl; 4F-iBF). Luxembourg: Joint Reports, Publications Office of the European Union. 14 p.

European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA–Europol Joint Report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]tetrahydrofuran-2-carboxamide (tetrahydrofuranylfentanyl; THF-F). Luxembourg: Joint Reports, Publications Office of the European Union. 13 p.

European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA–Europol Joint Report on a new psychoactive substance: methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA; 5F-ADB). Luxembourg: Joint Reports, Publications Office of the European Union. 16 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) EMCDDA–Europol joint report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-furan-2-carboxamide (furanylfentanyl). Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA–Europol 2016 annual report on the implementation of Council Decision 2005/387/JHA. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Ireland, country drug report 2017. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2017) European drug report 2017 trends and developments. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Perspectives on drugs: Synthetic cannabinoids in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 9 p.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Perspectives on drugs: Wastewater analysis and drugs — a European multi-city study. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 9 p.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Perspectives on drugs: changes in Europe’s cannabis resin market. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 6 p.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Perspectives on drugs: preventing overdose deaths in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) EMCDDA Best practice portal. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Legal approaches to drugs and driving. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] Monitoring hospital emergencies and acute drug toxicity in Europe: Euro-DEN Plus network expands reach by welcoming eight new centres. (09 Mar 2017)

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Communities That Care (CTC): a comprehensive prevention approach for communities. Luxembourg: Publications Office of the European Union. 28 p. DOI:10.2810/972747

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Report on the risk assessment of methyl 2-[[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]amino]-3,3-dimethylbutanoate (MDMB-CHMICA) in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union. 51 p. Risk Assessments 19

European Monitoring Centre for Drugs and Drug Addiction. (2017) Cannabis legislation in Europe: an overview. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2017) European Facility Survey Questionnaire (EFSQ) package. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA Programming document 2017–19. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA–Europol Joint Report on a new psychoactive substance: N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl). Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Healthy nightlife toolbox.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Drug supply reduction: an overview of EU policies and measures. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Drug trafficking penalties across the European Union: a survey of expert opinion. Technical report. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA strategy 2025. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2017) High-risk drug use and new psychoactive substances. Luxembourg: Publications Office of the European Union. 24 p. EMCDDA Rapid Communication

European Monitoring Centre for Drugs and Drug Addiction. (2017) Perspectives on drugs: Drug consumption rooms: an overview of provision and evidence. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 8 p.

Health Research Board. Irish National Focal Point to the European Monitoring Centre for Drugs and Drug Addiction. (2017) Ireland: national report for 2016 - drug markets and crime. Dublin: Health Research Board.

Health Research Board. Irish National Focal Point to the European Monitoring Centre for Drugs and Drug Addiction. (2017) Ireland: national report for 2016 - drugs. Dublin: Health Research Board.

Health Research Board. Irish National Focal Point to the European Monitoring Centre for Drugs and Drug Addiction. (2017) Ireland: national report for 2016 - harms and harm reduction. Dublin: Health Research Board.

Health Research Board. Irish National Focal Point to the European Monitoring Centre for Drugs and Drug Addiction. (2017) Ireland: national report for 2016 - prevention. Dublin: Health Research Board.

Health Research Board. Irish National Focal Point to the European Monitoring Centre for Drugs and Drug Addiction. (2017) Ireland: national report for 2016 - prison. Dublin: Health Research Board.

Health Research Board. Irish National Focal Point to the European Monitoring Centre for Drugs and Drug Addiction. (2017) Ireland: national report for 2016 - treatment. Dublin: Health Research Board.

Health Research Board. Irish National Focal Point to the European Monitoring Centre for Drugs and Drug Addiction. (2017) Ireland: national report for 2016 – drug policy. Dublin: Health Research Board.

Health Research Board. Irish National Focal Point to the European Monitoring Centre for Drugs and Drug Addiction. (2017) Ireland: national report for 2016 – legal framework. Dublin: Health Research Board.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2016) National drug-related public expenditure online resource. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2016) Drug-related infectious diseases in Europe: update from the EMCDDA expert network. Lisbon: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction and Eurojust. (2016) New psychoactive substances in Europe: legislation and prosecution — current challenges and solutions. Luxembourg: EMCDDA–Eurojust joint publication, Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2016) How can contingency management support treatment for substance use disorders? A systematic review. Luxembourg: Publications Office of the European Union. 46 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2016) Hospital emergency presentations and acute drug toxicity in Europe — update from the Euro-DEN Plus research group and the EMCDDA. Luxembourg: Publications Office of the European Union. 20 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2016) EMCDDA–Europol 2015 annual report on the implementation of Council Decision 2005/387/JHA. Luxembourg: Publications Office of the European Union. 26 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2016) Hepatitis C among drug users in Europe: epidemiology, treatment and prevention. Luxembourg: Publications Office of the European Union. 104 p. EMCDDA Insights 23

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2016) Report on the risk assessment of 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP). Luxembourg: Publications Office of the European Union. 48 p. Risk Assessments 18

European Monitoring Centre for Drugs and Drug Addiction. (2016) EMCDDA–Europol Joint report on a new psychoactive substance: methyl 2-[[1-(cyclohexylmethyl)indole-3-carbonyl]amino]-3,3-dimethylbutanoate (MDMB-CHMICA). Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2016) Health responses to new psychoactive substances. Luxembourg: Publications Office of the European Union. 30 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2016) Perspectives on drugs: Drug consumption rooms: an overview of provision and evidence. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 8 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2016) Perspectives on drugs: health responses to new psychoactive substances. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2016) EMCDDA–Europol joint report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-l]acetamide (acetylfentanyl),. Luxembourg: Publications Office of the European Union. 21 p. Joint reports

European Monitoring Centre for Drugs and Drug Addiction. (2016) General report of activities 2015 — Key achievements and governance: a year in review. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2016) European drug report 2016: trends and developments. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2016) Perspectives on drugs: changes in Europe’s cannabis resin market. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2016) Perspectives on drugs: cocaine trafficking to Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 6 p.

European Monitoring Centre for Drugs and Drug Addiction. (2016) Perspectives on drugs: strategies to prevent diversion of opioid substitution treatment medications. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 9 p.

European Monitoring Centre for Drugs and Drug Addiction. (2016) Recent changes in Europe’s MDMA/ecstasy market. EMCDDA rapid communication. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2016) Drugnet Europe 94. April–June . Lisbon: EMCDDA.

European Monitoring Centre for Drugs and Drug Addiction and Europol. (2016) EU drug markets report: in-depth analysis. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2016) Assessing illicit drugs in wastewater: advances in wastewater-based drug epidemiology. Luxembourg: Publications Office of the European Union. 18 p.

European Monitoring Centre for Drugs and Drug Addiction. (2016) The Internet and drug markets. EMCDDA.

European Monitoring Centre for Drugs and Drug Addiction. (2016) The internet and drug markets. Luxembourg: Publications Office of the European Union. 136 p. EMCDDA Insights 21

Strang, John and McDonald, Rebecca, eds. [EMCDDA] (2016) Preventing opioid overdose deaths with take-home naloxone. Luxembourg: Office for Official Publications of the European Communities. 104 p. EMCDDA Insights Series no. 20

European Monitoring Centre for Drugs and Drug Addiction. (2016) EMCDDA Strategy and work programme 2016–18: annual work programme 2016. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2016) Emergency department-based brief interventions for individuals with substance-related problems: a review of effectiveness. Luxembourg: Publications Office of the European Union. 20 p.

Health Research Board, Irish National Focal Point to the European Monitoring Centre for Drugs and Drug Addiction. (2016) Focal Point Ireland: national report for 2015. Dublin: Health Research Board.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Best practice in drug interventions: prescription medicines. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction, Europol. [EMCDDA] (2015) EMCDDA–Europol joint report on a new psychoactive substance: 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (α-PVP). Luxembourg: Publications Office of the European Union. 26 p.

European Monitoring Centre for Drugs and Drug Addiction. Buhler, Anneke and Thrul, Johannes [EMCDDA] . (2015) Prevention of addictive behaviours. Luxembourg: Publications Office of the European Union. 104 p. EMCDDA Insights Series no. 18

European Monitoring Centre for Drugs and Drug Addiction. (2015) Drug-related infectious diseases in Europe: update from the EMCDDA expert network. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Alternatives to punishment for drug-using offenders. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2015) EMCDDA-Europol 2014 annual report on the implementation of Council Decision 2005/387/JHA. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Drugs policy and the city in Europe. Luxembourg: Office for Official Publications of the European Communities. 25 p. EMCDDA Papers

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) New psychoactive substances in Europe: Innovative legal responses. Luxembourg: Publications Office of the European Union. 14 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Perspectives on drugs: Legal approaches to controlling new psychoactive substances. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 4 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Perspectives on drugs: Models for the legal supply of cannabis: recent developments. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 4 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Perspectives on drugs: The misuse of benzodiazepines among high-risk opioid users in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 8 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Perspectives on drugs: The role of psychosocial interventions in drug treatment. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 7 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Perspectives on drugs: Wastewater analysis and drugs — a European multi-city study. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 5 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Perspectives on drugs: opioid trafficking routes from Asia to Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 7 p.

European Monitoring Centre for Drugs and Drug Addiction. (2015) EMCDDA general population survey presentations. In: General population surveys annual expert meeting, 17–18 June 2015, Lisbon.

European Monitoring Centre for Drugs and Drug Addiction. (2015) European drug report 2015: trends and developments. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Perspectives on drugs: Hepatitis C treatment for injecting drug users. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 7 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Perspectives on drugs: Injection of synthetic cathinones. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 7 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Perspectives on drugs: Preventing overdose deaths in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 6 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Perspectives on drugs: Synthetic cannabinoids in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 5 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Perspectives on drugs: Synthetic drug production in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 5 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Perspectives on drugs: The EU drugs strategy (2013–20). Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 4 p.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Perspectives on drugs: Characteristics of frequent cannabis users with and without dependence. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 5 p.

European Monitoring Centre for Drugs and Drug Addiction. Schettino, Jonathan and Leuschner, Fabian and Kasten, Lorenz and Tossmann, Peter and Hoch, Eva and Ferri, Marica and Guarita, Bruno and Simon, Roland . (2015) Treatment of cannabis-related disorders in Europe.EMCDDA insights series no 17. Luxembourg: Publications Office of the European Union. 73 p.

European Monitoring Centre for Drugs and Drug Addiction. (2015) New psychoactive substances in Europe. An update from the EU Early Warning System March 2015. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Mortality among drug users in Europe: new and old challenges for public health. Luxembourg: Office for Official Publications of the European Communities. 21 p.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Internal statistics code of practice. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Preventing fatal overdoses: a systematic review of the effectiveness of take-home naloxone. Luxembourg: Publications Office of the European Union. 37 p. EMCDDA Papers

European Monitoring Centre for Drugs and Drug Addiction. (2015) Presentations from the Lisbon addictions conference 2015. In: EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs, 21-22 September, Lisbon.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Report on the risk assessment of 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45) in the framework of the Council Decision on new psychoactive substances. Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Report on the risk assessment of 4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4′-dimethylaminorex, 4,4′-DMAR) in the framework of the Council Decision on new psychoactive substances. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. [YouTube] Video: Take-home naloxone programmes in Europe — overdose prevention. (18 Dec 2014)

European Monitoring Centre for Drugs and Drug Addiction. (2014) Financing drug policy in Europe in the wake of the economic recession. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2014) EMCDDA-Europol 2013 annual report on the implementation of Council Decision 2005/387/JHA. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2014) EMCDDA–Europol joint report on a new psychoactive substance: 4,4′-DMAR (4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine. Luxembourg: Joint Reports, Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2014) EMCDDA–Europol 2013 annual report on the implementation of Council Decision 2005/387/JHA. Brussels: EMCDDA; Europol.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2014) Perspectives on drugs: Emergency health consequences of cocaine use in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 5 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2014) Perspectives on drugs: Health and social responses for methamphetamine users in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 6 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2014) Perspectives on drugs: Internet-based drug treatment. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 5 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2014) Perspectives on drugs: New developments in Europe's cannabis market. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 6 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2014) Perspectives on drugs: Treatment for cocaine dependence — reviewing current evidence. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 6 p.

European Monitoring Centre for Drugs and Drug Addiction. (2014) European drug report 2014: trends and developments. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Report on the risk assessment of 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one in the framework of the Council Decision on new psychoactive substances. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Report on the risk assessment of 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone in the framework of the Council Decision on new psychoactive substances. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Report on the risk assessment of 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine in the framework of the Council Decision on new psychoactive substances. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Report on the risk assessment of 3,4-dichloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide in the framework of the Council Decision on new psychoactive substances. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. Vanderplasschen, Wouter and Vandevelde, Stijn and Broekaert, Eric [EMCDDA] . (2014) Therapeutic communities for treating addictions in Europe. Luxembourg: Publications Office of the European Union. 95 p.

European Monitoring Centre for Drugs and Drug Addiction. Giraudon, Isabelle and Mena, Guillermo and Matias, Joao and Vicente, Julian (2014) Emergency health consequences of cocaine use in Europe. A review of the monitoring of drug-related acute emergencies in 30 European countries. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2014) The levels of use of opioids, amphetamines and cocaine and associated levels of harm: summary of scientific evidence. Luxembourg: Office for Official Publications of the European Communities. 53 p.

European Monitoring Centre for Drugs and Drug Addiction. (2014) EMCDDA. Work programme 2014. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Estimating public expenditure on drug-law offenders in prison in Europe. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. Montanari, Linda and Royuela, Luis and Rosa, Miriam and Vicente, Julian (2014) European questionnaire on drug use among prisoners (EQDP). Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. Royuela, Luis and Montanari, Linda and Rosa, Miriam and Vicente, Julian (2014) Drug use in prison: assessment report. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Exploring methamphetamine trends in Europe. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Multidimensional family therapy for adolescent drug users: a systematic review. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Report on the risk assessment of 4-methylamphetamine in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Report on the risk assessment of 5-(2-aminopropyl)indole in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union.

Europol, European Monitoring Centre for Drugs and Drug Addiction. (2014) EMCDDA–Europol Joint Report on a new psychoactive substance: 25I-NBOMe. (4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine). Lisbon: European Monitoring Centre for Drugs and Drug Addiction & EUROPOL.

Europol, European Monitoring Centre for Drugs and Drug Addiction. (2014) EMCDDA–Europol Joint report on a new psychoactive substance: AH-7921. (3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide). Lisbon: European Monitoring Centre for Drugs and Drug Addiction & EUROPOL.

Europol, European Monitoring Centre for Drugs and Drug Addiction. (2014) EMCDDA–Europol Joint report on a new psychoactive substance: methoxetamine (2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone). Lisbon: European Monitoring Centre for Drugs and Drug Addiction & EUROPOL.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Drug use, impaired driving and traffic accidents. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Drugnet Europe. 88 , (October–December) . Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction, European Centre for Disease Prevention and Control. (2014) EMCDDA and ECDC sub-regional exchange of knowledge and best practice in monitoring and preventing drug-related infections. In: Meeting reports, November 2013, Bucharest and Talinn.

European Monitoring Centre for Drugs and Drug Addiction. (2014) EMCDDA best practice portal: prevention interventions for partygoers.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2014) EMCDDA–Europol joint report on a new psychoactive substance: 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (‘MT-45’). Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2014) General report of activities 2013: Key achievements and governance: a year in review. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Pregnancy and opioid use: strategies for treatment, EMCDDA Papers. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Residential treatment for drug use in Europe. Luxembourg: Publications Office of the European Union.

Europol, European Monitoring Centre for Drugs and Drug Addiction. (2014) EMCDDA–Europol Joint report on a new psychoactive substance: MDPV (3,4-methylenedioxypyrovalerone). Lisbon: European Monitoring Centre for Drugs and Drug Addiction & EUROPOL.

European Monitoring Centre for Drugs and Drug Addiction. Laniel, Laurent and Kasecker, Rainer and Groshkova, Teodora and Carpentier, Chloe (2013) Drug squads: units specialised in drug law enforcement in Europe. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. Montanari, Linda and Pasinetti, Manuala and Thanki, Danica and Vicente, Julian (2013) Co-morbid substance use and mental disorders in Europe: a review of the data. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. O’Gorman, Aileen and Quigley, Eoghan and Zobel, Frank and Moore, Kerri (2013) Drug policy advocacy organisations in Europe. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. Quigley, Eoghan (2013) Drug supply reduction and internal security policies in the European Union: an overview. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. Brotherhood, Angelina and Sumnall, Harry [EMCDDA] . (2013) European drug prevention quality standards: a quick guide. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 38 p.

European Monitoring Centre for Drugs and Drug Addiction. EMCDDA welcomes European Commission call for stronger EU action on new drugs. (17 Sep 2013)

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2013) Models of addiction. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 166 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2013) Perspectives on drugs: Can mass media campaigns prevent young people from using drugs? Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 5 p.

European Monitoring Centre for Drugs and Drug Addiction. (2013) European drug report 2013: trends and developments. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2013) Drug prevention interventions targeting minority ethnic populations: issues raised by 33 case studies. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. New drug 4-MA to be placed under control across the EU. (07 Mar 2013)

European Monitoring Centre for Drugs and Drug Addiction. (2013) Women and drug use in Europe.

European Monitoring Centre for Drugs and Drug Addiction. (2013) Drug policy profiles — Ireland. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2013) EU drug markets report: a strategic analysis. Luxembourg: Publications Office of the European Union.

European Commission, European Monitoring Centre for Drugs and Drug Addiction. (2013) The second European conference on drug supply indicators: conclusions of the Chairs. Bruxelles: Council of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2013) Drug-related infectious diseases. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2013) EMCDDA–Europol 2012 Annual report on the implementation of Council Decision 2005/387/JHA (New drugs in Europe, 2012. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2013) EMCDDA–Europol Joint Report on a new psychoactive substance: 5-(2-aminopropyl)indole. Luxembourg: EMCDDA–Europol.

European Monitoring Centre for Drugs and Drug Addiction. (2013) European exchange on Brief Interventions and Motivational Interviewing for people using drugs. In: European exchange meeting, 23 January 2013, Lisbon.

European Monitoring Centre for Drugs and Drug Addiction. (2013) General report of activities 2012. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2013) North American drug prevention programmes: are they feasible in European cultures and contexts? Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2013) Work programme 2013. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] Driving under the influence of drugs, alcohol and medicines. New EMCDDA report reveals risks of substance use behind the wheel. (14 Dec 2012)

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2012) Standards and guidelines for practices. Web resource. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. Buster, Marcel and Giraudon, Isabelle and Matias, Joao and Vicente, Julian (2012) Mortality among drug users: guidelines for carrying out, analysing and reporting key figures 2011–12. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2012) Prisons and drugs in Europe: the problem and responses. Luxembourg: Publications Office of the European Union. 36 p.

European Monitoring Centre for Drugs and Drug Addiction. (2012) 2012 Annual report on the state of the drugs problem in Europe. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2012) Prevalence of daily cannabis use in the European Union and Norway. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. Sumnall, Harry and Brotherhood, Angelina [EMCDDA] . (2012) Social reintegration and employment: evidence and interventions for drug users in treatment. Luxembourg: Publications Office of the European Union. 208 p.

European Monitoring Centre for Drugs and Drug Addiction. (2012) Pregnancy, childcare and the family: key issues for Europe’s response to drugs. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2012) EMCDDA 2013–15 strategy and work programme. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2012) Travel and drug use in Europe: a short review. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2012) Treatment demand indicator (TDI) standard protocol 3.0: Guidelines for reporting data on people entering drug treatment in European countries. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2012) Guidelines for the evaluation of drug prevention: a manual for programme planners and evaluators. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 140 p.

European Monitoring Centre for Drugs and Drug Addiction. (2012) Drug demand reduction: global evidence for local actions. Drugs in Focus 23. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2012) Responding to drug use and related problems in recreational settings. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. Leading experts to review global developments in new drugs and ‘legal highs’. (07 Jun 2012)

European Monitoring Centre for Drugs and Drug Addiction. (2012) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 2011. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] New ESPAD study shows overall stable drug use among school students and a reduction in ‘heavy episodic drinking’, but no decrease in cigarette smoking. (31 May 2012)

European Monitoring Centre for Drugs and Drug Addiction. Early warning system - national profile. (25 May 2012)

European Monitoring Centre for Drugs and Drug Addiction. (2012) Drug-related research in Europe: recent developments and future perspectives. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. Gallegos, Ana and Sedefov, Roumen (2012) Early warning system: national profiles. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2012) EMCDDA: Prevention profile: Ireland. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2012) Overviews of legal topics. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2012) Work programme 2012. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2012) Legal topic overviews: classification of controlled drugs. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2012) Legal topic overviews: penalties for illegal drug trafficking. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2012) EMCDDA Trendspotter study on fentanyl in Europe. Luxembourg: Publications Office of the European Union. 14 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2012) EMCDDA-Europol joint report on a new psychoactive substance: 4-methylamphetamine. Luxembourg: Publications Office of the European Union. 40 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2012) Legal topic overviews: possession of cannabis for personal use. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2012) Cannabis production and markets in Europe. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2012) Drugnet Europe. 77 . Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2012) EMCDDA final annual accounts 2011. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2012) EMCDDA trend report for the evaluation of the 2005–12 EU drugs strategy. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2012) EMCDDA–Europol 2011 annual report on the implementation of Council Decision 2005/387/JHA. Lisbon: EMCDDA; Europol.

European Monitoring Centre for Drugs and Drug Addiction, European Centre for Disease Prevention and Control. (2012) Joint EMCDDA and ECDC rapid risk assessment. HIV in injecting drug users in the EU/EEA, following a reported increase of cases in Greece and Romania. Lisbon: European Monitoring Centre for Drugs and Drug Addiction; European Centre for Disease Prevention and Control.

European Monitoring Centre for Drugs and Drug Addiction. (2012) The Reitox network: frequently asked questions. Luxembourg: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2012) A definition of ‘drug mules’ for use in a European context. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. Schulze, Horst and Urmeew, Raschid and Auerbach, Kerstin and Alvarez, Javier and Bernhoft, Inger Marie and de Gier, Han and Hagenzieker, Marjan and Houwing, Sjoerd and Knoche, Anja and Pilgerstorfer, Monika and Zlender, Bojan (2012) Driving under the influence of drugs, alcohol and medicines in Europe — findings from the DRUID project. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. EMCDDA launches first European quality standards to improve drug prevention in the EU. (09 Dec 2011)

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2011) Amphetamine: a European Union perspective in the global context. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2011) Responding to new psychoactive substances. Drugs in Focus 22. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2011) Drugnet Europe 75. July–September . Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] Developing a set of indicators on drug markets, crime and supply reduction in Europe: your input is welcome. (13 May 2011)

European Monitoring Centre for Drugs and Drug Addiction. (2011) Drugnet Europe 74. April–June . Lisbon: EMCDDA.

European Monitoring Centre for Drugs and Drug Addiction. [European Monitoring Centre for Drugs and Drug Addiction] EMCDDA to acknowledge excellence in scientific writing. (04 Mar 2011)

European Monitoring Centre for Drugs and Drug Addiction. (2011) Drugnet Europe 73. January - March . Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Centre for Disease Prevention and Control, European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2011) ECDC and EMCDDA guidance. Prevention and control of infectious diseases among people who inject drugs. Stockholm: ECDC. 55 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2011) Guidelines for the treatment of drug dependence: a European perspective. Luxembourg: Publications Offi ce of the European Union. 30 p. 10.2810/49457

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2011) Hepatitis and drug use.

European Centre for Disease Prevention and Control, European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2011) Prevention and control of infectious diseases among people who inject drugs. Stockholm: European Centre for Disease Prevention and Control. 55 p.

European Monitoring Centre for Drugs and Drug Addiction. (2011) Annual report 2011: the state of the drugs problem in Europe. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2011) Cost and financing of drug treatment services in Europe. Luxembourg: Publications Offi ce of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2011) EMCDDA manuals no 7. European drug prevention quality standards. A manual for prevention professionals. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2011) EMCDDA: Work programme 2011. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2011) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 2010. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2011) Khat use in Europe: implications for European policy. Luxembourg: Office for Offical Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2011) Mortality related to drug use in Europe. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2011) Online sales of new psychoactive substances/'legal highs': summary of results from the 2011 multilingual snapshots. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2011) Pilot study on wholesale drug prices in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2011) Prevention profiles 2011. European Monitoring Centre for Drugs and Drug Addiction, Lisbon.

European Monitoring Centre for Drugs and Drug Addiction. (2011) Statistical bulletin 2011. European Monitoring Centre for Drugs and Drug Addiction, Lisbon.

European Monitoring Centre for Drugs and Drug Addiction. Sedefov, Roumen and Gallegos, Ana (2011) Report on the risk assessment of mephedrone in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. [European Monitoring Centre for Drugs and Drug Addiction] Europe faces new challenges posed by changes in drug supply and use. (10 Nov 2010)

European Monitoring Centre for Drugs and Drug Addiction. [European Monitoring Centre for Drugs and Drug Addiction] Over 1 million drug users a year in treatment, but considerable challenges remain. (10 Nov 2010)

European Monitoring Centre for Drugs and Drug Addiction. (2010) EMCDDA statistical bulletin 2010. European Monitoring Centre for Drugs and Drug Addiction, Lisbon.

European Monitoring Centre for Drugs and Drug Addiction. [European Monitoring Centre for Drugs and Drug Addiction] Drug use and pregnancy: challenges for public health. (01 Jul 2010)

European Monitoring Centre for Drugs and Drug Addiction. (2010) Drugnet Europe 71. July–September . Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2010) EMCDDA 2010 selected issue: trends in injecting drug use in Europe. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2010) EMCDDA manuals no 4. Prevention and evaluation resources kit (PERK). Luxembourg: The Publications Office of the European Union. 100 p.

European Monitoring Centre for Drugs and Drug Addiction. (2010) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 2009. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. Olszewski, Deborah and Burkhart, Gregor and Bo, Alessandra (2010) Thematic paper. Children's voices. Experiences and perceptions of European children on drug and alcohol issues. Luxembourg:: The Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction & EUROPOL. (2010) Europol–EMCDDA joint report on a new psychoactive substance: 4-methylmethcathinone (mephedrone). Lisbon: European Monitoring Centre for Drugs and Drug Addiction & EUROPOL.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2010) EMCDDA–Europol 2009 Annual Report on the implementation of Council Decision 2005/387/JHA. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [European Monitoring Centre for Drugs and Drug Addiction] Harm reduction moves to the mainstream: EU drugs agency publishes major work on harm reduction: past, present and future. (23 Apr 2010)

European Monitoring Centre for Drugs and Drug Addiction. (2010) Harm reduction: evidence, impacts and challenges. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2010) EMCDDA manuals no 5. Guidelines for collecting data on retail drug prices in Europe: issues and challenges. Luxembourg: The Publications Office of the European Union. 136 p.

European Monitoring Centre for Drugs and Drug Addiction. (2010) Risk assessment of new psychoactive substances — operating guidelines. Luxembourg: The Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2010) EMCDDA manuals no 6. Guidelines for testing HIV, viral hepatitis and other infections in injecting drug users. A manual for provider-initiated voluntary medical examination, testing and counselling. Luxembourg: The Publications Office of the European Union. 75 p.

European Monitoring Centre for Drugs and Drug Addiction. (2010) Annual report 2010: the state of the drugs problem in Europe. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2010) Cocaine: A European Union perspective in the global context. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2010) Drugnet Europe 72. October–December . Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction, European Commission. (2010) The European Union and the drug phenomenon: frequently asked questions. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2010) First European conference on drug supply indicators — key conclusions. Lisbon: European Monitoring Centre for Drugs and Drug Addiction .

European Monitoring Centre for Drugs and Drug Addiction. (2010) Problem amphetamine and methamphetamine use in Europe. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2010) Risk assessment report of a new psychoactive substance: 4-methylmethcathinone (mephedrone). Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2010) Treatment and care for older drug users. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction, Inter-American Drug Abuse Control Commission of the Organization of American States. Goosdeel, Alexis (2010) Building a national drugs observatory: a joint handbook. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2009) EMCDDA conference proceedings: identifying Europe's information needs for effective drug policy. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2009) Annual report 2009: the state of the drugs problem in Europe. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2009) Drug offences: sentencing and other outcomes. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2009) EMCDDA 2009 Thematic paper: Understanding the 'Spice' phenomenon. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2009) Polydrug use: patterns and responses. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2009) Factsheet from the EU drugs agency in Lisbon: responding to the drugs driving in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. Decorte, Tom and Mortelmans, Dimitri and Tieberghien, Julie and De Moor, Sabine (2009) Drug use: an overview of general population surveys in Europe. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2009) Summary: The 2007 ESPAD report. Substance use among students in 35 countries. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2009) Thematic paper: Women’s voices: experiences and perceptions of women facing drug problems. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2009) Addiction neurobiology: ethical and social implications. EMCDDA Scientific Monograph Series; No. 9 Luxembourg: Office for Official Publications of the European Communities .

European Monitoring Centre for Drugs and Drug Addiction. (2009) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 2008. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2009) Neurobiological research on drugs: ethical and policy implications. Drugs in Focus , 19 , pp. 1-4.

European Monitoring Centre for Drugs and Drug Addiction. (2009) Preventing later substance use disorders in at-risk children and adolescents. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2009) Report on the risk assessment of BZP in the framework of the Council decision on new psychoactive substances. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2009) Responding to drug driving in Europe. Drugs in Focus , (20) .

European Monitoring Centre for Drugs and Drug Addiction. Tossmann, Dr Hans-Peter and Leuschner, Fabian (2009) Internet-based drug treatment interventions: best practice and applications in EU Member States. EMCDDA Insights Series no. 10 Lisbon: European Monitoring Centre for Drugs and Drug Addiction .

European Monitoring Centre for Drugs and Drug Addiction. (2008) Assessing illicit drugs in wastewater. EMCDDA Insights Series no. 9. Luxembourg: Office for Official Publications of the European Communities .

European Monitoring Centre for Drugs and Drug Addiction. (2008) Drug use, impaired driving and traffic accidents. EMCDDA Insights Series no. 8. Luxembourg: Office for Official Publications of the European Communities .

European Monitoring Centre for Drugs and Drug Addiction. (2008) EMCDDA 2008 selected issue - Drugs and vulnerable groups of young people. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2008) EMCDDA 2008 selected issue - National drug-related research in Europe. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2008) EMCDDA 2008 selected issue - Towards a better understanding of drug-related public expenditure in Europe. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2008) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Annual report 2008: the state of the drugs problem in Europe. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2008) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 2007. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2008) GHB and its precursor GBL: an emerging trend case study. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2008) Monitoring the supply of cocaine to Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2008) Monitoring the supply of heroin to Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2008) Prevention of substance abuse. EMCDDA Insights Series no. 7 Luxembourg: Office for Official Publications of the European Communities .

European Monitoring Centre for Drugs and Drug Addiction. (2008) Sexual assaults facilitated by drugs or alcohol. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2008) Thematic paper on indicated prevention. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2008) A cannabis reader: global issues and local experiences. EMCDDA Scientific Monograph Series; No. 8 Luxembourg: Office for Official Publications of the European Communities .

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2007) Guidelines for the evaluation of treatment in the field of problem drug use; a manual for researchers and professionals. Luxembourg: Office for Official Publications of the European Communities. 76 p.

European Monitoring Centre for Drugs and Drug Addiction. (2007) EMCDDA 2007 selected issue - Drug use and related problems among very young people (under 15 years old). Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2007) EMCDDA 2007 selected issue - Drugs and driving. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2007) EMCDDA 2007 selected issue - cocaine and crack cocaine: a growing public health issue. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2007) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Annual report 2007: the state of the drugs problem in Europe. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2007) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 2006. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2007) Treatment of problem cocaine use: a review of the literature. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. King, Leslie A and Sedefov, Roumen (2007) Early-warning system on new psychoactive substances: operating guidelines. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2006) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Annual Report 2006: The state of the drugs problem in Europe. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2006) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) annual report 2005: the state of the drugs problem in Europe. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2006) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) annual report 2006: selected issues. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2006) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 2005. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2006) Hallucinogenic mushrooms. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2006) Monitoring new drugs. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2005) Differences in patterns of drug use between women and men. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2005) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) annual report 2005: selected issues. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2005) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 2004. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2005) Illicit drug use in the EU: legislative approaches. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2005) Youth media. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2004) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 2004 Annual report: the state of the drugs problem in the European Union and Norway. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2004) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 2003. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2004) Report on the risk assessment of 2C-I, 2C-T-2 and 2C-T-7 in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2004) Report on the risk assessment of TMA-2 in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. Hedrich, Dagmar (2004) European report on drug consumption rooms. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Kretzschmar, Mirjam and Wiessing, Lucas and Jager, Johannes and Limburg, Wien and Postma, Maarten, eds. (2004) Hepatitis C and injecting drug use: impact, costs and policy options. EMCDDA Scientific Monograph Series; No. 7 Luxembourg: Office for Official Publications of the European Communities .

European Monitoring Centre for Drugs and Drug Addiction. (2003) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) annual report 2003: the state of the drugs problem in the European Union and Norway. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2003) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 2002. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2003) European Monitoring Centre for Drugs and Drug Addiction annual report 2003: the state of the drugs problem in the acceding and candidate countries to the European Union. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2002) Annual report on the state of the dugs problem in the European Union and Norway 2002. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2002) Early-warning system on new synthetic drugs: guidance on implementation. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2002) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): Report on the drug situation in the candidate CEECs 2002. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2002) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 2001. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2002) Prosecution of drug users in Europe: varying pathways to similar objectives. EMCDDA Insight Series Luxembourg: Office for Official Publications of the European Communities .

European Monitoring Centre for Drugs and Drug Addiction. (2002) Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2002) Report on the risk assessment of PMMA in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2002) Report on the risk assessment of ketamine in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2001) Annual report on the state of the drugs problem in the European Union 2001. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2001) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 2000. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2001) Guidelines for the evaluation of outreach work: a manual for outreach practitioners. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. Fountain, Jane and Rhodes, Tim and Barnard, Marina and Hariga, Fabienne and Avilés, Nuria Romo and Vicente, Julian and Weber, Urban (2001) Injecting drug use, risk behaviour and qualitative research in the time of AIDS. EMCDDA Insights Series no. 4 Luxembourg: Office for Official Publications of the European Communities .

Sharp, Frances and Neaman, Rachel, eds. (2001) Modelling drug use: methods to quantify and understand hidden processes. EMCDDA Scientific Monograph Series No. 6 Luxembourg: Office for Official Publications of the European Communities .

European Monitoring Centre for Drugs and Drug Addiction. (2000) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) annual report on the state of the drugs problem in the European Union 2000. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2000) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 1999. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2000) Reviewing current practice in drug-substitution treatment in the European Union. EMCDDA Insights Series no. 3 Luxembourg: Office for Official Publications of the European Communities .

Neaman, Rachel and Nilson, Margareta and Solberg, Ulrik, eds. (2000) Evaluation: a key tool for improving drug prevention. EMCDDA Scientific Monograph Series; No. 5 Luxembourg: Office for Official Publications of the European Communities .

Robertson, Kathy and Greenwood, Gloria, eds. (2000) Understanding and responding to drug use: the role of qualitative research. EMCDDA Scientific Monograph Series No. 4 Luxembourg: Office for Official Publications of the European Communities .

European Monitoring Centre for Drugs and Drug Addiction. (1999) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 1998. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (1999) Evaluating the treatment of drug abuse in the European Union. EMCDDA Scientific Monograph Series; No. 3 Luxembourg: Office for Official Publications of the European Communities .

European Monitoring Centre for Drugs and Drug Addiction. (1999) Extended annual report on the state of the drugs problem in the European Union 1999. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (1999) Final report: demand reduction networking in Austria, Ireland, the Netherlands, Spain and Sweden. Stockholm: National Institute of Public Health.

European Monitoring Centre for Drugs and Drug Addiction. (1999) Guidelines for the risk assessment of new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (1999) Literature review on the relation between drug use, impaired driving and traffic accidents. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (1999) Report on the risk assessment of 4-MTA in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (1999) Report on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (1999) Scientific review of the literature on estimating the prevalence of drug misuse on the local level. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Korf, Dirk and Freeman, Marielle and Lewis, Roger and Grant, Ian and Jacob, Elisabeth and Mougin, Chantal and Nilson, Margareta, eds. (1999) Outreach work among drug users in Europe: concepts, practice and terminology. EMCDDA Insights Series no. 2 Luxembourg: Office for Official Publications of the European Communities .

European Monitoring Centre for Drugs and Drug Addiction. (1998) Annual report on the state of the drugs problem in the European Union 1998. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (1998) Annual report on the state of the drugs problem in the European Union 1998: summary and highlights. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (1998) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 1997. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (1998) Evaluating drug prevention in the European Union. EMCDDA Scientific Monograph Series; No. 2 Luxembourg: Office for Official Publications of the European Communities .

European Monitoring Centre for Drugs and Drug Addiction. (1998) Guidelines for the evaluation of drug prevention: a manual for programme planners and evaluators. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (1997) Annual report on the state of the drugs problem in the European Union 1997. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (1997) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 1996. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction, European University Institute. (1997) Joint seminar. Drugs: research initiatives in the European Union: synthesis report. Florence: EMCDDA; European University Institute.

European Monitoring Centre for Drugs and Drug Addiction. (1997) Literature review of studies of mortaility and feasibility study for a common methodology. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Griffiths, Paul and Vingoe, Louisa and Jansen, Karl and Sherval, James and Lewis, Roger and Hartnoll, Richard and Nilson, Margareta, eds. (1997) New trends in synthetic drugs in the EU: epidemiology and demand-reduction responses. EMCDDA Insights Series no. 1 Luxembourg: Office for Official Publications of the European Communities .

Stimson, Gerry V and Hickman, Matthew and Quirk, Alan and Frischer, Martin and Taylor, Colin, eds. (1997) Estimating the prevalence of problem drug use in Europe. Papers arising from a scientific seminar on addiction prevalence estimation: methods and research strategies held in Strasbourg, France, 10-14 June 1996. EMCDDA Scientific Monograph Series; No. 1 Luxembourg: Office for Official Publications of the European Communities .

European Monitoring Centre for Drugs and Drug Addiction. (1996) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): general report of activities 1995. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (1995) Annual report on the state of the drugs problem in the European Union 1995. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. Hartnoll, Richard (1993) Annotated bibliography of epidemiological research on illicit drugs in Europe. Volume two annexes. Lisbon: EMCDDA.